USPTO serial 86235551
JBM
Reviewed by CopyMark Law Group
Reg. 4769851Status 710
- Filing date
- Status date
- Registration date
- Jul 7, 2015
- Examiner
- SHANAHAN, PATRICK
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with JBM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Changzhi, Pingtung Co., TW
Changzhi, Pingtung Co., TW
Changzhi, Pingtung Co., TW
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Chao-Chang David Pai
CHAO-CHANG DAVID PAI PAI PATENT & TRADEMARK LAW FIRM1001 4TH AVE STE 3200SEATTLE, WA 98154-1003UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Dietary and nutritional supplements; Fungal extracts sold as a component ingredient of nutritional supplements and vitamins; Health food supplements; Nutraceuticals for use as a dietary supplement; Nutritional food additives for medical purposes in the nature of natural food extracts derived from Antrodia camphorate; Nutritional supplements; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Powdered nutritional supplement concentrate; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Therapeutic pharmaceutical for the treatment of hepatoprotective, cholesterol-lowering, promoting blood circulation and boosting metabolism, regulation in blood pressure, regulation in blood lipids, regulation in blood sugar, immunomodulatory, promoting immune system, regulation of allergy | SECTION 8 - CANCELLED | Mar 17, 2015 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 14, 2022 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jul 7, 2020 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jul 7, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 2, 2015 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jun 1, 2015 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| May 11, 2015 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| May 11, 2015 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Apr 6, 2015 | IUAF | USE AMENDMENT FILED | — |
| Apr 6, 2015 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Oct 21, 2014 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 26, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 26, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 6, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 23, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 22, 2014 | ALIE | ASSIGNED TO LIE | — |
| Jul 7, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 7, 2014 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 7, 2014 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 7, 2014 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 7, 2014 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 30, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 12, 2014 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Apr 11, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 1, 2014 | NWAP | NEW APPLICATION ENTERED | — |